Amsterdam, Noord-Holland, The Netherlands In 1991 was created PPF Group, which is appeared as VC. The leading representative office of defined VC is situated in the Amsterdam. The venture was found in Europe in The Netherlands.
We can highlight the next thriving fund investment areas, such as Media and Entertainment, Content. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the location of its establishment and the land of its numerous investments - Switzerland. Among the most popular portfolio startups of the fund, we may highlight Culture Trip, MaveriX Oncology, CytunePharma.
This organization was formed by Petr Kellner.
The standard case for the fund is to invest in rounds with 1-2 partakers. Despite the PPF Group, startups are often financed by GoBeyond, Boehringer Ingelheim Venture Fund, Pierre Barbe. The meaningful sponsors for the fund in investment in the same round are FC Capital, Boehringer Ingelheim Venture Fund, Partners Investment. In the next rounds fund is usually obtained by Novo Holdings, GoBeyond, Future Fifty.
Considering the real fund results, this VC is 50 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2018. The fund is constantly included in 2-6 investment rounds annually. This PPF Group works on 9 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity.
| Fund Name | Location |
| BankInvest | Copenhagen, Denmark, Hovedstaden |
| Bhoruka Finance | - |
| Bradley Family Trust | Milwaukee, United States, Wisconsin |
| Capture Investments | - |
| Centuria Ventures | Arkansas, Fort Smith, United States |
| Dahua Technology | Binjiang, China, Jiangxi |
| Emerging Growth Management | - |
| Footpath Ventures | New York, New York, United States |
| Footprint Ventures | Bangalore, India, Karnataka |
| HC2 | Herndon, United States, Virginia |
| Hitotoki Incubator | Chiba, Japan, Minato |
| Innovation Factory (Canada) | Canada, Hamilton, Ontario |
| Innovation Ulster | Newtownabbey, Northern Ireland, United Kingdom |
| Malin Corporation | County Dublin, Dublin, Ireland |
| MTM | Missouri, St Louis, United States |
| Raine Ventures | California, San Francisco, United States |
| SAIC Venture Capital | Las Vegas, Nevada, United States |
| Taijing Touzi | Beijing, Beijing, China |
| TOTVS | Brazil, São Paulo, Sao Paulo |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Culture Trip | $46M | 25 Aug 2020 | London, England, United Kingdom | ||
NBE-Therapeutics | $22M | 10 Jan 2020 | Basel, Basel-City, Switzerland | ||
Cellestia Biotech | $21M | 17 Dec 2019 | Lausanne, Vaud, Switzerland | ||
MaveriX Oncology | $6M | 14 Oct 2019 | Palo Alto, California, United States | ||
Cellestia Biotech | $21M | 19 Dec 2018 | Lausanne, Vaud, Switzerland | ||
NBE-Therapeutics | $21M | 28 Jun 2018 | Basel, Basel-City, Switzerland | ||
Culture Trip | $116M | 24 Apr 2018 | London, England, United Kingdom | ||
Cellestia Biotech | $8M | 26 Jan 2017 | Lausanne, Vaud, Switzerland | ||
NBE-Therapeutics | $21M | 03 Nov 2016 | Basel, Basel-City, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Culture Trip | $46M | 25 Aug 2020 | London, England, United Kingdom | ||
NBE-Therapeutics | $22M | 10 Jan 2020 | Basel, Basel-City, Switzerland | ||
Cellestia Biotech | $21M | 17 Dec 2019 | Lausanne, Vaud, Switzerland | ||
MaveriX Oncology | $6M | 14 Oct 2019 | Palo Alto, California, United States | ||
Cellestia Biotech | $21M | 19 Dec 2018 | Lausanne, Vaud, Switzerland | ||
NBE-Therapeutics | $21M | 28 Jun 2018 | Basel, Basel-City, Switzerland | ||
Culture Trip | $116M | 24 Apr 2018 | London, England, United Kingdom | ||
Cellestia Biotech | $8M | 26 Jan 2017 | Lausanne, Vaud, Switzerland | ||
NBE-Therapeutics | $21M | 03 Nov 2016 | Basel, Basel-City, Switzerland |
